Literature DB >> 17187068

HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease).

Christoph Klein1, Magda Grudzien, Giridharan Appaswamy, Manuela Germeshausen, Inga Sandrock, Alejandro A Schäffer, Chozhavendan Rathinam, Kaan Boztug, Beate Schwinzer, Nima Rezaei, Georg Bohn, Malin Melin, Göran Carlsson, Bengt Fadeel, Niklas Dahl, Jan Palmblad, Jan-Inge Henter, Cornelia Zeidler, Bodo Grimbacher, Karl Welte.   

Abstract

Autosomal recessive severe congenital neutropenia (SCN) constitutes a primary immunodeficiency syndrome associated with increased apoptosis in myeloid cells, yet the underlying genetic defect remains unknown. Using a positional cloning approach and candidate gene evaluation, we identified a recurrent homozygous germline mutation in HAX1 in three pedigrees. After further molecular screening of individuals with SCN, we identified 19 additional affected individuals with homozygous HAX1 mutations, including three belonging to the original pedigree described by Kostmann. HAX1 encodes the mitochondrial protein HAX1, which has been assigned functions in signal transduction and cytoskeletal control. Here, we show that HAX1 is critical for maintaining the inner mitochondrial membrane potential and protecting against apoptosis in myeloid cells. Our findings suggest that HAX1 is a major regulator of myeloid homeostasis and underline the significance of genetic control of apoptosis in neutrophil development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17187068     DOI: 10.1038/ng1940

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  139 in total

Review 1.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  Registries for study of nonmalignant hematological diseases: the example of the Severe Chronic Neutropenia International Registry.

Authors:  David C Dale; Audrey Anna Bolyard; Laurie A Steele; Cornelia Zeidler; Karl Welte
Journal:  Curr Opin Hematol       Date:  2020-01       Impact factor: 3.284

3.  Kostmann disease with developmental delay in three patients.

Authors:  Caner Aytekin; Manuela Germeshausen; Nilden Tuygun; Gonul Tanir; Figen Dogu; Aydan Ikinciogullari
Journal:  Eur J Pediatr       Date:  2010-02-23       Impact factor: 3.183

4.  Activation of the unfolded protein response is associated with impaired granulopoiesis in transgenic mice expressing mutant Elane.

Authors:  Suparna Nanua; Mark Murakami; Jun Xia; David S Grenda; Jill Woloszynek; Marie Strand; Daniel C Link
Journal:  Blood       Date:  2011-02-01       Impact factor: 22.113

Review 5.  Genetic and molecular diagnosis of severe congenital neutropenia.

Authors:  Alister C Ward; David C Dale
Journal:  Curr Opin Hematol       Date:  2009-01       Impact factor: 3.284

Review 6.  Genetic heterogeneity in severe congenital neutropenia: how many aberrant pathways can kill a neutrophil?

Authors:  Alejandro A Schäffer; Christoph Klein
Journal:  Curr Opin Allergy Clin Immunol       Date:  2007-12

7.  Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia.

Authors:  Jun Xia; Audrey A Bolyard; Elin Rodger; Steve Stein; Andrew A Aprikyan; David C Dale; Daniel C Link
Journal:  Br J Haematol       Date:  2009-09-22       Impact factor: 6.998

8.  Growth factor independence 1 (Gfi1) regulates cell-fate decision of a bipotential granulocytic-monocytic precursor defined by expression of Gfi1 and CD48.

Authors:  Lothar Vassen; Ulrich Dührsen; Christian Kosan; Hui Zeng; Tarik Möröy
Journal:  Am J Blood Res       Date:  2012-11-25

Review 9.  Kostmann's Disease and HCLS1-Associated Protein X-1 (HAX1).

Authors:  Christoph Klein
Journal:  J Clin Immunol       Date:  2016-12-10       Impact factor: 8.317

Review 10.  Genetic insights into congenital neutropenia.

Authors:  Christoph Klein; Karl Welte
Journal:  Clin Rev Allergy Immunol       Date:  2010-02       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.